Wesseling, Jelle
The Netherlands Cancer Institute
2 papers on CoChatORCID 0000-0002-8940-2676
Most cited papers
- Verified
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature
Melanoma and MAPK PathwaysLung Cancer Treatments and Mutations
Cited by 888
- Verified
BRCA1 -Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
Lips, E. H., Debipersad, R. D., Scheerman, C. E., Mulder, L., Sonke, G. S., van der Kolk, L. E., Wesseling, J., Hogervorst, F. B. L., & Nederlof, P. M. (2017) · Clinical Cancer Research
BRCA gene mutations in cancerPARP inhibition in cancer therapy
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free